Erbitux (cetuximab) - Eli Lilly
andecaliximab (GS-5745) - Gilead
pazopanib - Generic mfg.
Cejemly (sugemalimab) - CStone Pharma
Opdivo (nivolumab) - BMS
Vyloy (zolbetuximab-clzb) - Astellas
Cyramza (ramucirumab) - Eli Lilly
bemarituzumab (AMG 552) - Amgen
onartuzumab (RG3638) - Roche
Keytruda (pembrolizumab) - Merck (MSD)
ipatasertib (RG7440) - Roche
rilotumumab (AMG 102) - Amgen
Tevimbra (tislelizumab-jsgr) - BeiGene
Tyvyt (sintilimab) - Eli Lilly
https://www.ispor.org/heor-resources/presentations-database/presentation/euro2024-4014/141368
 
Smyth E 1; Kangappaden T 2; Portuhay S 2; Debnath A 2; Craigie S 2; Coaquira Castro J 3; Priedane E 4; Zhan L 3
 
Nov 5, 2024
 
Prev Next